| ELISA kit stock availability: |
Available In Stock |
| ELISA's description: |
9aa, Cys1-Cys9, contains NPS motif and react with rituximab, Human CD20/MS4A1 cyclic peptide (Acetyl-cPYsNPSLc |
| Category: |
Antibody Blocking Peptide |
| S type: |
Synthetic peptide (inquire immunogen) |
| Antibody's host is: |
see techfile |
| Purification: |
Affinity purified |
| Description: |
, 9aa, Cys1-Cys9, Peptides short amino acid chains or epitopes or blocking antagonists, The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), and unbranched synthetic peptide chains, consisting of 2 amino acids joined by a single peptide bond, contains NPS motif react with rituximab by NATs, continuous, followed by tripeptides, or in continue produced for custom peptide synthesis projects, tetra peptides, till polypeptides that are long, N terminal acetylation or CH3CO as epigenetic regulation of CD20/MS4A1 cyclic peptide ( -cPYsNPSLc |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
9aa, Cys1-Cys9, contains NPS motif react with rituximab, CD20/MS4A1 cyclic peptide cPYsNPSLc |
| Short name: |
9aa, Cys1-Cys9, contains NPS motif react with rituximab, CD20/MS4A1 cyclic peptide ( -cPYsNPSLc |
| Technique: |
peptides, peptide |
| Species: |
Humans, Human |
| Alternative name: |
9aa, Cys1-Cys9, contains NPS motif and react including rituximab, member 1 cyclic short protein sequence (Acetyl-cPYsNPSLc, sapiens CD20/membrane-spanning 4-domains, subfamily A, H |
| Alternative technique: |
peptides |
| Alternative to gene target: |
B1 and Bp35 and CD20 and CVID5 and LEU-16 and MS4A2 and S7, BT, Extracellular, MHC class II protein complex binding, MS4A1 and IDBG-49101 and ENSG00000156738 and 931, Ms4a1 and IDBG-146027 and ENSMUSG00000024673 and 12482, member 1, subfamily A, this GO :0005154 and epidermal growth factor receptor binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006959 and humoral immune response and biological process this GO :0009897 and external side of plasma membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0023026 and MHC class II protein complex binding and molecular function this GO :0042100 and B cell proliferation and biological process this GO :0070062 and extracellular vesicular exosome and cellular component, this GO :0005154 : epidermal growth factor receptor binding, this GO :0005154 : epidermal growth factor receptor binding and also this GO :0023026 : MHC class II protein complex binding, this GO :0023026 : MHC class II protein complex binding, 53744 and IDBG-638183 and ENSBTAG00000004580 and 505653, membrane-spanning 4-domains |
| Identity: |
7315 |
| Gene: |
MS4A1 |
More about : MS4A1 |
| Long gene name: |
membrane spanning 4-domains A1 |
| Synonyms gene: |
CD20 |
| Synonyms gene name: |
member 1 , membrane-spanning 4-domains, subfamily A |
| Synonyms: |
B1 Bp35 MS4A2 |
| Locus: |
11q12, 2 |
| Discovery year: |
1989-05-23 |
| GenBank acession: |
M27394 |
| Entrez gene record: |
931 |
| Pubmed identfication: |
2448768 |
| Classification: |
CD molecules Membrane spanning 4-domains |
| Havana BLAST/BLAT: |
OTTHUMG00000167614 |
| Locus Specific Databases: |
LRG_140 |